These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 10448519)

  • 1. Nonoxidative modifications of lipoproteins in atherogenesis.
    Tabas I
    Annu Rev Nutr; 1999; 19():123-39. PubMed ID: 10448519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subendothelial retention of atherogenic lipoproteins in early atherosclerosis.
    Skålén K; Gustafsson M; Rydberg EK; Hultén LM; Wiklund O; Innerarity TL; Borén J
    Nature; 2002 Jun; 417(6890):750-4. PubMed ID: 12066187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Modified LDL and atherosclerosis. Nature of modifications. Physicochemical and biological properties].
    Pech MA; Myara I; Vedie B; Moatti N
    Ann Biol Clin (Paris); 1992; 50(4):213-27. PubMed ID: 1456499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atherogenic, dense low-density lipoproteins. Pathophysiology and new therapeutic approaches.
    Chapman MJ; Guérin M; Bruckert E
    Eur Heart J; 1998 Feb; 19 Suppl A():A24-30. PubMed ID: 9519339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipoproteins, macrophage function, and atherosclerosis: beyond the foam cell?
    Rader DJ; Puré E
    Cell Metab; 2005 Apr; 1(4):223-30. PubMed ID: 16054067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Initial Human Atherosclerotic Lesion and Lipoprotein Modification-A Deep Connection.
    Torzewski M
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Front line of oxidized lipoproteins: role of oxidized lipoproteins in atherogenesis and cardiovascular disease risk].
    Yoshida H
    Rinsho Byori; 2010 Jun; 58(6):622-30. PubMed ID: 20662275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retention of atherogenic lipoproteins in atherogenesis.
    Gustafsson M; Flood C; Jirholt P; Borén J
    Cell Mol Life Sci; 2004 Jan; 61(1):4-9. PubMed ID: 14704849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The low density lipoprotein and low density lipoprotein receptors and their possible importance in the pathogenesis of atherosclerosis.
    Dresel HA; Friedrich EA; Otto I; Waldherr R; Schettler G
    Arzneimittelforschung; 1985; 35(12A):1936-40. PubMed ID: 3913426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Secretory sphingomyelinase, a product of the acid sphingomyelinase gene, can hydrolyze atherogenic lipoproteins at neutral pH. Implications for atherosclerotic lesion development.
    Schissel SL; Jiang X; Tweedie-Hardman J; Jeong T; Camejo EH; Najib J; Rapp JH; Williams KJ; Tabas I
    J Biol Chem; 1998 Jan; 273(5):2738-46. PubMed ID: 9446580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of modification of lipoproteins and of the immune system in early atherogenesis.
    Mol MJ; Demacker PN; Stalenhoef AF
    Neth J Med; 1993 Aug; 43(1-2):83-90. PubMed ID: 8232700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The mast cell--a potential link between inflammation and cellular cholesterol deposition in atherogenesis.
    Kovanen PT
    Eur Heart J; 1993 Dec; 14 Suppl K():105-17. PubMed ID: 8131778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of oxidized low-density lipoproteins in the pathogenesis of atherosclerosis.
    Parthasarathy S; Steinberg D; Witztum JL
    Annu Rev Med; 1992; 43():219-25. PubMed ID: 1580586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of extracellular retention of low density lipoproteins in atherosclerosis.
    Borén J; Gustafsson M; Skålén K; Flood C; Innerarity TL
    Curr Opin Lipidol; 2000 Oct; 11(5):451-6. PubMed ID: 11048887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electronegative low-density lipoprotein. A link between apolipoprotein B misfolding, lipoprotein aggregation and proteoglycan binding.
    Sánchez-Quesada JL; Villegas S; Ordóñez-Llanos J
    Curr Opin Lipidol; 2012 Oct; 23(5):479-86. PubMed ID: 22964994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modified forms of low density lipoprotein and atherosclerosis.
    Aviram M
    Atherosclerosis; 1993 Jan; 98(1):1-9. PubMed ID: 8457244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipoprotein-mediated cellular mechanisms for atherogenesis in hypertriglyceridemia.
    Gianturco SH; Bradley WA
    Semin Thromb Hemost; 1988 Apr; 14(2):165-9. PubMed ID: 3061002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Autoimmune theory of atherogenesis and the concept of modified lipoproteins].
    Klimov AN
    Vestn Akad Med Nauk SSSR; 1990; (11):30-6. PubMed ID: 2284842
    [No Abstract]   [Full Text] [Related]  

  • 19. Oxidative modifications of LDL increase its binding to extracellular matrix from human aortic intima: influence of lesion development, lipoprotein lipase and calcium.
    Wang X; Greilberger J; Ratschek M; Jürgens G
    J Pathol; 2001 Sep; 195(2):244-50. PubMed ID: 11592105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The role of lipoproteins and macrophages in the development of atherosclerosis].
    Bjørneboe GE
    Tidsskr Nor Laegeforen; 1989 Jan; 109(2):216-9. PubMed ID: 2916204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.